Synapse - Nikoletta Lendvai

Results (106)

Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma

Meeting Abstract

Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma

Meeting Abstract

Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study

Meeting Abstract

Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies

Journal Article

Cohen, A. D.; Garfall, A. L.; Dogan, A.; Lacey, S. F.; Martin, C.; Lendvai, N.; Vogl, D. T.; Spear, M.; Lesokhin, A. M.
Blood Advances (2019)

Fulltext@MSK | Save

Autologous lymphocyte infusion supports tumor antigen vaccine-induced immunity in autologous stem cell transplant for multiple myeloma

Journal Article

Cohen, A. D.; Lendvai, N.; Nataraj, S.; Imai, N.; Jungbluth, A. A.; Tsakos, I.; Rahman, A.; Mei, A. H. C.; Singh, H.; Zarychta, K.; more...
Cancer Immunology Research (2019)

Fulltext@MSK | Save

Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: An update on safety and efficacy from dose expansion phase I study

Journal Article

Trudel, S.; Lendvai, N.; Popat, R.; Voorhees, P. M.; Reeves, B.; Libby, E. N.; Richardson, P. G.; Hoos, A.; Gupta, I.; Bragulat, V.; more...
Blood Cancer Journal (2019)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
Blood (2018)

Fulltext@MSK | Save

Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence

Meeting Abstract

Yellapantula, V. D.; Rustad, E. H.; Glozdik, D.; Gundem, G.; Fan, J.; Medina, J.; Patel, A.; Patel, M.; Hultcrantz, M.; Peled, J. U.; more...
Blood (2018)

Fulltext@MSK | Save

Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy

Meeting Abstract

Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
Blood (2018)

Fulltext@MSK | Save